ArticleBiomedical optics express2024

Prediction of the response to antiangiogenic sunitinib therapy by non-invasive hybrid diffuse optics in renal cell carcinoma.

Miguel Mireles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.